Patents by Inventor Aaron DUMAS

Aaron DUMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGFR INHIBITORS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20250243204
    Abstract: The disclosure is in part directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide, its salts, its cocrystals, and variants thereof.
    Type: Application
    Filed: October 15, 2024
    Publication date: July 31, 2025
    Inventors: André Lescarbeau, Jethro Beamish-Cook, Zoe Prentice, Thomas Kendall, Aaron Dumas, Elisabeth Isaak, Piera Trinchera, Oleksandr Zhurakovskyi, Osama Suleiman
  • PYRYLIUM METHOD OF PREPARING PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20250011290
    Abstract: The present invention provides methods of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators, methods of preparing intermediates of pyrimidine cyclohexyl glucocorticoid receptor modulators, and pyridinium compounds.
    Type: Application
    Filed: May 28, 2024
    Publication date: January 9, 2025
    Inventors: Hazel Joan Hunt, Gary Patrick Reid, Jeffrey Mark Dener, Aaron Dumas, Stephen Hyde, Conor Marrett-Munro, Shaun Stairs, Christopher Wise
  • SULFONE METHOD OF PREPARING PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20250002462
    Abstract: The present invention provides methods of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators, methods of preparing intermediates of pyrimidine cyclohexyl glucocorticoid receptor modulators, and thioether compounds.
    Type: Application
    Filed: May 28, 2024
    Publication date: January 2, 2025
    Inventors: Hazel Joan Hunt, Gary Patrick Reid, Jeffrey Mark Dener, Aaron Dumas, Stephen Hyde, Liam McLean, Shaun Stairs, Christopher Wise
  • FGFR inhibitors and methods of making and using the same
    Patent number: 12152034
    Abstract: The disclosure is in part directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide represented by the following structure: its salts, its cocrystals, and variants thereof.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: November 26, 2024
    Assignee: Relay Therapeutics, Inc.
    Inventors: André Lescarbeau, Jethro Beamish-Cook, Zoe Prentice, Thomas Kendall, Aaron Dumas, Elisabeth Isaak, Piera Trinchera, Oleksandr Zhurakovskyi, Osama Suleiman
  • FGFR INHIBITORS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20220194946
    Abstract: The disclosure is in part directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-(4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide, its salts, its cocrystals, and variants thereof.
    Type: Application
    Filed: November 18, 2021
    Publication date: June 23, 2022
    Inventors: André LESCARBEAU, Jethro BEAMISH-COOK, Zoe PRENTICE, Thomas KENDALL, Aaron DUMAS, Elisabeth ISAAK, Piera TRINCHERA, Oleksandr ZHURAKOVSKYI, Osama SULEIMAN